Quarterly report · Q2
8938.TEDINET S100S9IC
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥484m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥96m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥111m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | −¥124m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥268m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥238m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥112m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥291m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥99m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥348m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥249m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥99m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥251m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥8.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥594m | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥426m | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.9bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥44m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥755m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥409m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥65m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥769m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥777m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥45m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥364m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥362m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-10.99 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.83 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.47 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.59 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.7 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 90.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥192m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥418m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥418m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥75m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥66m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥20m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥484m |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥484m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥95m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥484m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥95m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥241m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥623m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥623m |
| jpcrp040300-q2r_E04034-000Medical Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥258m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥643m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥643m |
| jpcrp040300-q2r_E04034-000Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥94m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥353m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥353m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 530
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net ope cf | Prior1YTDDuration | -42000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -40000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 506000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -38000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 0 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -3000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | － | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -94000000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | -16000000 | JPY |
| Proceeds from insurance income ope cf | Prior1YTDDuration | － | JPY |
| Proceeds from insurance income ope cf | CurrentYTDDuration | 9000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 409000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -44000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -11000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -2000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -0 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1000000 | JPY |
| Payments of loans receivable inv cf | Prior1YTDDuration | -50000000 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | － | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | 839000000 | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | 102000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | -33000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 777000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | 65000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -307000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -0 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -54000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -45000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -362000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -45000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | － | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | － | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 825000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -24000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1848000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 2964000000 | JPY |
| Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cce | Prior1YTDDuration | -45000000 | JPY |
| Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cce | CurrentYTDDuration | － | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 2628000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 2939000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -24000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 111000000 | JPY |
| Directors compensations sga | Prior1YTDDuration | 44000000 | JPY |
| Directors compensations sga | CurrentYTDDuration | 42000000 | JPY |
| Salaries sga | Prior1YTDDuration | 150000000 | JPY |
| Salaries sga | CurrentYTDDuration | 148000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |